What Should a Peptide Certificate of Analysis Actually Show?

What a Certificate of Analysis actually tells you

A Certificate of Analysis, commonly called a COA, is a document summarizing analytical testing performed on a particular sample or batch.

At a glance, a COA can look definitive. It may display a compound name, batch number, purity percentage, test date, and a laboratory name or logo.

But the existence of a COA does not by itself establish how thoroughly a sample was characterized.

The more useful question is: What was actually tested, which analytical methods were used, and what evidence supports the reported results?

Start with sample and batch identification

One of the most basic features of useful analytical documentation is clear identification of the material that was tested.

A COA should make it possible to connect the analytical results to a particular sample or production batch. Information may include a compound name, batch or lot number, sample identifier, test date, and other traceable information.

Without that connection, even sophisticated analytical results can be difficult to meaningfully associate with a particular vial or batch.

Identity and purity answer different questions

Two of the most commonly confused measurements on peptide COAs are identity and purity.

Chromatographic purity, often measured using HPLC, describes the relative chromatographic signal associated with the primary peak compared with other detected peaks under the conditions of that method.

Identity asks whether the material represented by that peak is actually consistent with the compound it is claimed to be.

Techniques such as mass spectrometry can provide evidence about molecular mass and help support compound identity.

A sample can therefore produce a very high chromatographic purity result while identity remains a separate analytical question.

Purity does not establish peptide content

A purity percentage also should not automatically be interpreted as the amount of peptide contained in a vial.

For example, a chromatogram could show that the overwhelming majority of detected peptide-related signal belongs to one primary component. That may produce a result such as 99%+ chromatographic purity.

But that percentage alone does not establish that a vial labeled 10 mg actually contains 10 mg of peptide.

Determining peptide content or quantity requires an analytical approach designed to answer that separate question.

Look at the analytical method

A number without a method provides limited context.

Useful analytical documentation identifies how the result was obtained. Depending on the question being investigated, methods may include HPLC or UHPLC, mass spectrometry, quantitative assays, or other analytical techniques.

Method conditions also matter because analytical techniques differ in resolution, selectivity, sensitivity, and the types of substances they are capable of detecting.

This is one reason two apparently similar purity percentages should not necessarily be treated as analytically equivalent.

Supporting data matters

A COA that reports “99.8% purity” provides a result. A chromatogram provides additional information about how that result was produced.

Likewise, mass-spectrometry data can provide evidence relevant to molecular identity that a chromatographic purity number alone cannot.

Supporting analytical data may therefore provide useful context beyond the summary values printed on the certificate.

The goal is not simply to collect more pages of documentation. It is to understand what evidence actually supports each analytical claim.

Who performed the testing?

Analytical documentation should also make clear who performed the analysis and when it occurred.

Useful information can include the laboratory name, test date, report or sample number, analytical method, and personnel or approval information where applicable.

These details help establish traceability and provide context for interpreting the results.

A COA is only as informative as the testing behind it

Professional formatting, logos, signatures, and impressive percentages can make a Certificate of Analysis appear authoritative.

But presentation is not analytical evidence.

A stronger way to evaluate a peptide COA is to ask several separate questions:

• Is the sample clearly identified?

• Was identity evaluated?

• How was purity measured?

• Was peptide content or quantity evaluated separately?

• Are the analytical methods identified?

• Is supporting analytical data available?

• Can the results be connected to the laboratory, date, and specific sample or batch tested?

A useful COA does not reduce peptide quality to one impressive number. It provides enough information to understand what was measured, how it was measured, and what the results can and cannot establish.